VivoSim Labs, Inc. (VIVS)
0.1561
+0.01
(+7.14%)
USD |
NASDAQ |
Oct 29, 16:00
0.153
0.00 (0.00%)
After-Hours: 20:00
VivoSim Labs Profit Margin (Quarterly) : -7.43K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.43K% |
| March 31, 2026 | -14.41K% |
| December 31, 2025 | -10.35K% |
| September 30, 2025 | -9.09K% |
| June 30, 2025 | -7.68K% |
| March 31, 2025 | |
| December 31, 2024 | -14.36K% |
| September 30, 2024 | -8.50K% |
| June 30, 2024 | -8.57K% |
| March 31, 2024 | -10.50K% |
| December 31, 2023 | -72.08K% |
| September 30, 2023 | |
| June 30, 2023 | -5.37K% |
| March 31, 2023 | -4.60K% |
| December 31, 2022 | -2.49K% |
| September 30, 2022 | -4.31K% |
| June 30, 2022 | |
| March 31, 2022 | -127.4% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | -1.13K% |
| September 30, 2019 | -511.7% |
| June 30, 2019 | -946.6% |
| March 31, 2019 | -1.03K% |
| December 31, 2018 | -821.4% |
| September 30, 2018 | -619.0% |
| June 30, 2018 | -1.08K% |
| March 31, 2018 | -674.1% |
| December 31, 2017 | -675.7% |
| September 30, 2017 | -698.2% |
| June 30, 2017 | -1.02K% |
| March 31, 2017 | -1.31K% |
| December 31, 2016 | -832.4% |
| September 30, 2016 | -686.2% |
| June 30, 2016 | -984.0% |
| March 31, 2016 | -1.53K% |
| December 31, 2015 | -3.19K% |
| September 30, 2015 | -3.74K% |
| June 30, 2015 | -2.77K% |
| March 31, 2015 | -2.92K% |
| December 31, 2014 | -4.51K% |
| September 30, 2014 | -17.72K% |
| June 30, 2014 | -6.50K% |
| March 31, 2014 | -5.64K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | -1.64% |
| Amgen, Inc. | 23.59% |
| Anika Therapeutics, Inc. | 10.15% |
| BioCryst Pharmaceuticals, Inc. | 35.92% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -350.5% |
| Return on Assets | -154.3% |
| Return on Invested Capital | -291.5% |
| Gross Profit Margin (Quarterly) | -122.2% |
| Operating Margin (Quarterly) | -15.33K% |
| Return on Net Operating Assets | -1.23K% |